Open label, prospective, randomized trial to study the effect of teriparatide and denosumab combination therapy in postmenopausal osteoporosis patients

Trial Profile

Open label, prospective, randomized trial to study the effect of teriparatide and denosumab combination therapy in postmenopausal osteoporosis patients

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Aug 2016

At a glance

  • Drugs Denosumab (Primary) ; Teriparatide (Primary)
  • Indications Postmenopausal osteoporosis
  • Focus Pharmacodynamics
  • Most Recent Events

    • 19 Aug 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top